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In 1964, Ernst Beutner and Robert Jordon reported in the
Proceedings of the Society of Experimental Biology and
Medicine the observation of circulating antibodies to a
component of the skin in pemphigus patients, demonstrating
that pemphigus is an autoimmune disease [1]. In 1965 they
and their co-workers reported in JAMA the deposition of IgG
in the skin in pemphigus patients [2], and in 1967 the group
reported the finding of basement membrane zone antibodies
in pemphigoid [3]. The review in the JID by Beutner, Jordon,
and Tadeusz Chorzelski in 1968 [4] summarizes their work
and the work of their colleagues in this area, and has become
one of the most frequently cited articles from the JID.
Some important groundwork was laid for these studies by
Coons and co-workers [5], who developed the techniques of
fluorescent antibody examination, and by Lever [6], who
recognized the distinction between pemphigus and pemphi-
goid, based on their respective histologic findings.
At the beginning of the studies of autoantibodies in
pemphigus and pemphigoid, Beutner was a member of the
Department of Microbiology in the School of Medicine of the
State University of New York in Buffalo. He had a very early
introduction to the scientific method, because his father and his
grandparents were scientists. His father, Reinhard Beutner, was
a professor of pharmacology and researcher in electrophysio-
logy at Buffalo and kept a laboratory in the basement of their
home. He instilled in his son an appreciation for the
importance of developing reliable techniques for scientific
studies. This appreciation, developed early in life, would
pay off when the immunofluorescent techniques Dr. Beutner
methodically and painstakingly devised facilitated the
discovery of autoantibodies in the skin in pemphigus and
pemphigoid. His careful definitions of the important quantita-
tive and qualitative parameters in direct and indirect immuno-
fluorescence continue to be useful.
At the beginning of their studies, Bob Jordon was a
medical student at SUNY-Buffalo. He, too, was a scion of a
scientist. His father, James W. Jordon, was an academic
dermatologist and chairman of the Department of Dermato-
logy in Buffalo. James Jordon was acknowledged in the
pemphigus and pemphigoid papers of Ernst Beutner and
Robert Jordon as having ‘‘made the initial suggestions that led
to the exploration of these dermatologic problems’’ [3].
Bob Jordon began his work with Beutner during the
summer after his freshman year in medical school and
continued the work during medical school. He made use of
an NIH summer research fellowship and chose Dr. Beutner
because he was interested in histopathology. Dr. Beutner
was at the time working in the field of autoimmunity, having
been stimulated to do so by Dr. Ernest Witebsky, his first
mentor in immunology, the founder of his department in
Buffalo, and an active investigator in the area of autoimmune
thyroiditis.
Jordon set out to employ Beutner’s techniques for indirect
immunofluorescence, using the skin as substrate. At first,
Jordon worked out general techniques by looking at anti-
nuclear antibodies. Much key work has been done in this
area by Burnham and co-workers [7], whose important
contributions to immunopathologic studies of the skin have
been mentioned elsewhere in this journal. Jordon found that
using unfixed tissue gave generally better results, because
fixatives often destroyed important antigens. After the
procedures to be used were established, sera from patients
with various skin diseases were examined. The dermatology
clinics in Buffalo routinely drew serum samples from large
numbers of their patients, so that a large store of sera was
readily available for study. Although there was distinctive
fluorescence of the skin with the first pemphigus serum
examined, Jordon and Beutner were not yet certain of the
validity of the finding. When they saw the same immuno-
fluorescent pattern with the second pemphigus patient’s
serum, they began to feel more confident that their results
were indeed significant and exciting.
Tadeusz Chorzelski read the report of Beutner and Jordon
and was immediately interested. Dr. Chorzelski had attended
medical school in Warsaw, and had been encouraged by
Dr. Stefania Jablonska to make dermatology his career. When
Beutner and Jordon’s report appeared, Chorzelski was doing
postdoctoral work in Boston with Dr. Walter Lever. Several
years before, he and his colleagues in Warsaw had examined
pemphigus sera for antibodies, but had not found any
evidence of autoantibodies using immunofluorescent techni-
ques. He felt that technical advances in immunofluorescence
might now make it possible for him to confirm the presence
of pemphigus antibodies. During his fellowship in Boston, he
had arranged to learn immunofluorescent techniques from
Dr. Coons. After the paper from Beutner and Jordon
appeared, Chorzelski set about the very important task of
confirming the work, and was the first to verify Beutner and
Jordon’s results independently. He was also able by following
patients serially to correlate levels of circulating pemphigus
antibodies with disease activity, a finding which provided
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evidence for the direct involvement of pemphigus antibodies
in the disease process [8].
Among the control sera available to Jordon in the original
pemphigus studies were two sera that yielded positive
staining at the basement membrane zone. The clinical
information about these patients was then retrieved, and
these patients indeed had a blistering disease. The histology
of this disease fit what Lever described as bullous pemphi-
goid, and thus came about the second major original
observation from the collaboration of Jordon and Beutner,
that of antibodies to the basement membrane zone in bullous
pemphigoid [3].
Although the presence of circulating autoantibodies to the
surface of keratinocytes in pemphigus and to the basement
membrane zone in pemphigoid was certainly suggestive of a
pathogenetic role in these diseases, Beutner and Jordon
began to be convinced of the pathogenicity of the antibodies
when they found deposits of IgG in the appropriate locations
in the skin in pemphigus and pemphigoid patients. The
finding by Chorzelski that circulating levels of pemphigus
antibodies correlated with disease activity was further
support in favor of the involvement of the antibodies in the
disease process. Additional evidence for the pathogenicity of
pemphigus antibodies came with studies of experimental
pemphigus in laboratory animals, both those detailed in the
JID review and the later work of Anhalt and co-workers [9].
After completing medical school, Dr. Jordon went on to
make dermatology his career. His continuing interest in
pemphigus, pemphigoid, and related diseases is evidenced
by considerable investigation in these areas over the years.
He is now chairman of the Department of Dermatology at the
University of Texas at Houston. Dr. Beutner has remained in
Buffalo, where he has carried on an active collaboration with
Russell Nisengard, Vijay Kumar, Susan Krasny, and Jay
Huang. He has also carried on a long-standing and produc-
tive collaboration with Dr. Chorzelski and Dr. Jablonska.
Dr. Chorzelski visits Buffalo almost yearly for several weeks
at a time, and Dr. Beutner makes regular visits to Warsaw.
Chorzelski and Beutner have co-authored more than 100
papers together.
The application of immunofluorescent techniques to the
study of pemphigus and pemphigoid resulted in an invaluable
diagnostic tool, whose availability has significantly affected
the management of patients with these diseases. This is one of
the best examples of how advances in dermatologic
investigation can directly affect patient care. The importance
of this work has been recognized not only in dermatology but
also in the medical community as a whole. The articles of
Beutner, Jordon, and co-workers that appeared in JAMA [2,3]
have been recognized by that journal as ‘‘citation classics,’’
indicating that they are among the 100 most cited articles that
appeared in JAMA between 1955 and 1983 [10].
The work reviewed in the JID in 1968 by Beutner, Jordon,
and Chorzelski occurred at a time when immunopathologic
techniques were at their advent in dermatology. These key
reports undoubtedly played a pivotal role in the increasing
use of immunopathology to study skin disease. This work has
stimulated interest in dermatologic research in numerous
young investigators and has helped to insure the prominence
of dermatology in immunopathology investigations. It is
fitting that the authors presented ‘‘The Immunopathology of
Pemphigus and Bullous Pemphigoid’’ in the pages of the JID.
The author is grateful to Dr. Beutner, Dr. Jordon, and Dr. Chorzelski for their helpful and
entertaining remembrances of a very exciting time in dermatologic research.
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